Oyster Point Outlines Restructuring Plan With Savings Of Up To $48M In 2023

  • Oyster Point Pharma Inc OYST will implement an operating expense streamlining plan to reduce employee and non-employee expenses (up to 50 roles) across the organization. 
  • The company plans to continue to drive the launch of Tyrvaya with approximately 150-200 field-based sales resources.
  • The plan is expected to reduce operating expenses by approximately $6 million - $8 million in 2H of 2022 and approximately $40 million - $48 million in 2023. 
  • Related: FDA Approves First Nasal Spray For Dry Eye Disease From Oyster Point Pharma.
  • To reflect these strategic priorities, the company is also announcing that Daniel Lochner, its current CFO, will take on additional responsibilities now, serving in a dual role as the CFO and Chief Business Officer.
  • The company will focus its R&D efforts on OC-01 (varenicline solution) nasal spray to target stage 1 neurotrophic keratopathy and Enriched Tear Film (ETF) gene therapy to target stages 2 and 3 neurotrophic keratopathy. 
  • The company expects study results for the OLYMPIA Phase 2 clinical trial for Stage 1 Neurotrophic Keratopathy during Q4 of 2022. 
  • The company has submitted a Pre-IND meeting request to the FDA regarding the ETF Gene Therapy program and expects to hold the meeting during 2H of 2022.
  • Price Action: OYST shares closed lower by 7.16% at $4.67 on Tuesday.

Posted In: BriefsJob cutsBiotechNewsPenny StocksHealth CareGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.